Robust, reproducible clinical patterns in hospitalised patients with COVID-19

Millar, Jonathan ORCID: 0000-0002-4853-9377, Neyton, Lucile ORCID: 0000-0003-1273-2228, Seth, Sohan ORCID: 0000-0002-7464-4752, Dunning, Jake ORCID: 0000-0002-4035-4562, Merson, Laura, Murthy, Srin ORCID: 0000-0002-9476-839X, Russell, Clark ORCID: 0000-0002-9873-8243, Keating, Sean ORCID: 0000-0001-8552-5604, Swets, Maaike ORCID: 0000-0003-0901-9560, Sudre, Carole ORCID: 0000-0001-5753-428X
et al (show 10 more authors) (2020) Robust, reproducible clinical patterns in hospitalised patients with COVID-19.

Access the full-text of this item by clicking on the Open Access link.


<h4>Background</h4> Severe COVID-19 is characterised by fever, cough, and dyspnoea. Symptoms affecting other organ systems have been reported. However, it is the clinical associations of different patterns of symptoms which influence diagnostic and therapeutic decision-making. In this study, we applied simple machine learning techniques to a large prospective cohort of hospitalised patients with COVID-19 identify clinically meaningful sub-groups. <h4>Methods</h4> We obtained structured clinical data on 59 011 patients in the UK (the ISARIC Coronavirus Clinical Characterisation Consortium, 4C) and used a principled, unsupervised clustering approach to partition the first 25 477 cases according to symptoms reported at recruitment. We validated our findings in a second group of 33 534 cases recruited to ISARIC-4C, and in 4 445 cases recruited to a separate study of community cases. <h4>Findings</h4> Unsupervised clustering identified distinct sub-groups. First, a core symptom set of fever, cough, and dyspnoea, which co-occurred with additional symptoms in three further patterns: fatigue and confusion, diarrhoea and vomiting, or productive cough. Presentations with a single reported symptom of dyspnoea or confusion were common, and a subgroup of patients reported few or no symptoms. Patients presenting with gastrointestinal symptoms were more commonly female, had a longer duration of symptoms before presentation, and had lower 30-day mortality. Patients presenting with confusion, with or without core symptoms, were older and had a higher unadjusted mortality. Symptom clusters were highly consistent in replication analysis using a further 35446 individuals subsequently recruited to ISARIC-4C. Similar patterns were externally verified in 4445 patients from a study of self-reported symptoms of mild disease. <h4>Interpretation</h4> The large scale of the ISARIC-4C study enabled robust, granular discovery and replication of patient clusters. Clinical interpretation is necessary to determine which of these observations have practical utility. We propose that four patterns are usefully distinct from the core symptom groups: gastro-intestinal disease, productive cough, confusion, and pauci-symptomatic presentations. Importantly, each is associated with an in-hospital mortality which differs from that of patients with core symptoms. These observations deepen our understanding of COVID-19 and will influence clinical diagnosis, risk prediction, and future mechanistic and clinical studies. <h4>Funding</h4> Medical Research Council; National Institute Health Research; Well-come Trust; Department for International Development; Bill and Melinda Gates Foundation; Liverpool Experimental Cancer Medicine Centre.

Item Type: Article
Uncontrolled Keywords: ISARIC-4C Investigators
Depositing User: Symplectic Admin
Date Deposited: 08 Jan 2021 15:23
Last Modified: 22 Apr 2021 13:10
DOI: 10.1101/2020.08.14.20168088
Open Access URL: